Vergote, Ignace

ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma

Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M. R., Marnitz, S., Ledermann, J., Bosse, T., Chargari, C., Fagotti, A., et al. (2021) · International Journal of Gynecological Cancer

Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatment

Cited by 1,989

Simple ultrasound-based rules for the diagnosis of ovarian cancer

Timmerman, D., Testa, A. C., Bourne, T., Ameye, L., Jurkovic, D., Van Holsbeke, C., Paladini, D., Van Calster, B., Vergote, I., Van Huffel, S., et al. (2008) · Ultrasound in Obstetrics & Gynecology

Ovarian cancer diagnosis and treatmentBreast Lesions and Carcinomas

Cited by 613

Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer

Monk, B. J., Herzog, T. J., Kaye, S. B., Krasner, C. N., Vermorken, J. B., Muggia, F. M., Pujade-Lauraine, E., Lisyanskaya, A. S., Makhson, A. N., Rolski, J., et al. (2010) · Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 395

Surgical treatment of deeply infiltrating endometriosis with colorectal involvement

Meuleman, C., Tomassetti, C., D'Hoore, A., Van Cleynenbreugel, B., Penninckx, F., Vergote, I., & D'Hooghe, T. (2011) · Human Reproduction Update

Endometriosis Research and TreatmentEndometrial and Cervical Cancer Treatments

Cited by 338

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

EMBRACE, Kuchenbaecker, K. B., Collaborators, G. S., Breast Cancer Family Registry, HEBON, KConFab Investigators, Australian Cancer Study (Ovarian Cancer Investigators), Australian Ovarian Cancer Study Group, the Consortium of Investigators of Modifiers of BRCA1 and BRCA2, Ramus, S. J., et al. (2015) · Nature Genetics

BRCA gene mutations in cancerOvarian cancer diagnosis and treatment

Cited by 250

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models

Maenhoudt, N., Defraye, C., Boretto, M., Jan, Z., Heremans, R., Boeckx, B., Hermans, F., Arijs, I., Cox, B., Van Nieuwenhuysen, E., et al. (2020) · Stem Cell Reports

Ovarian cancer diagnosis and treatmentCancer Cells and Metastasis

Cited by 186

Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses

Timmerman, D., Verrelst, H., Bourne, T. H., De Moor, B., Collins, W. P., Vergote, I., & Vandewalle, J. (1999) · Ultrasound in Obstetrics & Gynecology

Ovarian cancer diagnosis and treatmentAI in cancer detection

Cited by 134

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

Melief, C. J. M., Welters, M. J. P., Vergote, I., Kroep, J. R., Kenter, G. G., Ottevanger, P. B., Tjalma, W. A. A., Denys, H., van Poelgeest, M. I. E., Nijman, H. W., et al. (2020) · Science Translational Medicine

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 134

Port-site metastases after open laparoscopy: A study in 173 patients with advanced ovarian carcinoma

Vergote, I., Marquette, S., Amant, F., Berteloot, P., & Neven, P. (2005) · International Journal of Gynecological Cancer

Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments

Cited by 133

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

Timmerman, D., Planchamp, F., Bourne, T., Landolfo, C., du Bois, A., Chiva, L., Cibula, D., Concin, N., Fischerova, D., Froyman, W., et al. (2021) · Ultrasound in Obstetrics & Gynecology

Ovarian cancer diagnosis and treatmentMRI in cancer diagnosis

Cited by 114

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2

Monk, B. J., Poveda, A., Vergote, I., Raspagliesi, F., Fujiwara, K., Bae, D.-S., Oaknin, A., Ray-Coquard, I., Provencher, D. M., Karlan, B. Y., et al. (2016) · Gynecologic Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 98

Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer

Moore, K. N., O'Malley, D. M., Vergote, I., Martin, L. P., Gonzalez-Martin, A., Malek, K., & Birrer, M. J. (2018) · Gynecologic Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 82

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

Marth, C., Vergote, I., Scambia, G., Oberaigner, W., Clamp, A., Berger, R., Kurzeder, C., Colombo, N., Vuylsteke, P., Lorusso, D., et al. (2017) · European Journal of Cancer

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 79

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

Mahner, S., Meier, W., du Bois, A., Brown, C., Lorusso, D., Dell’Anna, T., Cretin, J., Havsteen, H., Bessette, P., Zeimet, A. G., et al. (2015) · European Journal of Cancer

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 70

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer

Mungenast, F., Aust, S., Vergote, I., Vanderstichele, A., Sehouli, J., Braicu, E., Mahner, S., Castillo-Tong, D. C., Zeillinger, R., & Thalhammer, T. (2017) · Oncology Letters

Ovarian cancer diagnosis and treatmentEstrogen and related hormone effects

Cited by 33

PISARRO: A EUTROC phase 1b study of APR-246 with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in relapsed platinum-sensitive high grade serous ovarian cancer (HGSOC)

Basu, B., Gourley, C., Gabra, H., Vergote, I. B., Brenton, J. D., Abrahmsen, L., Smith, A., Von Euler, M., & Green, J. A. (2016) · Annals of Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 8